Research & Literature

[A man with a painful index finger].

Hutting KH, Bouwer LR, Keukens FM

Nederlands tijdschrift voor geneeskunde 2016; (160()):A9686.

IL36RN Mutations Affect Protein Expression and Function: A Basis for Genotype-Phenotype Correlation in Pustular Diseases.

Tauber M, Bal E, Pei XY, et al.

The Journal of investigative dermatology 2016; (136(9)):1811-1819 doi:10.1016/j.jid.2016.04.038.

Short- and Long-Term Management of an Acute Pustular Psoriasis Flare: A Case Report.

Georgakopoulos JR, Ighani A, Yeung J

Journal of cutaneous medicine and surgery 2017; (21(5)):452-456 doi:10.1177/1203475417712499.

Dermoscopy in facilitating the recognition of acrodermatitis continua of Hallopeau.

Errichetti E, Stinco G

The Journal of dermatology 2017; (44(11)):e286-e287 doi:10.1111/1346-8138.13978.

Acrodermatitis Continua of Hallopeau with Bone Resorption in an 8-Year-Old Patient: A Case Report.

Alorainy M, Alshaya M, Al-Rikabi A, et al.

Case reports in dermatology 2017; (9(3)):259-264 doi:10.1159/000485370.

Treatment of acrodermatitis continua of Hallopeau with ustekinumab as monotherapy after failure of anti-TNF agents.

Palacios-Álvarez I, Simal-Gómez G, Mas-Vidal A, Bernad-Alonso I

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2018; (16(5)):611-613 doi:10.1111/ddg.13506.

A case of acrodermatitis continua of Hallopeau (ACH) successfully treated with sulfasalazine.

Li M, Zhang Y, Xu H, et al.

Dermatologic therapy 2018; (31(3)):e12595 doi:10.1111/dth.12596.

Acrodermatitis continua of Hallopeau successfully treated with adalimumab: A case report.

Crowley EL, Maliyar K, Rodriguez-Bolanos F, et al.

SAGE open medical case reports 2019; (7()):2050313X19829620 doi:10.1177/2050313X19829620.

Biologic therapy for acrodermatitis continua of Hallopeau: Successful treatment with secukinumab and review of the literature.

Galluzzo M, D'Adamio S, Teoli M, et al.

Dermatologic therapy 2019; (32(3)):e12899 doi:10.1111/dth.12899.

Nails as immune-privileged sites: A case of disabling Acrodermatitis continua of Hallopeau successfully treated with Apremilast.

Lanna C, Cesaroni GM, Mazzilli S, et al.

Dermatologic therapy 2019; (32(4)):e12946 doi:10.1111/dth.12946.

Outcomes of various types of therapy in patients with treatment-resistant acrodermatitis continua of Hallopeau.

Smirnova LM, Vertieva EY, Olisova OY, Anpilogova EM

Biologics : targets & therapy 2019; (13()):83-87 doi:10.2147/BTT.S199100.

Juvenile-onset pustular psoriasis: case series and literature review.

Huang YW, Tsai TF

The British journal of dermatology 2020; (182(3)):816-817 doi:10.1111/bjd.18473.

Acrodermatitis continua of Hallopeau: clinical perspectives.

Smith MP, Ly K, Thibodeaux Q, et al.

Psoriasis (Auckland, N.Z.) 2019; (9()):65-72 doi:10.2147/PTT.S180608.

Efficacy and safety of TNF blockers and of ustekinumab in palmoplantar pustulosis and in acrodermatitis continua of Hallopeau.

Husson B, Barbe C, Hegazy S, et al.

Journal of the European Academy of Dermatology and Venereology : JEADV 2020; (34(10)):2330-2338 doi:10.1111/jdv.16265.

Clinical characteristics, genetics, comorbidities and treatment of palmoplantar pustulosis: A retrospective analysis of 66 cases in a single center in Taiwan.

Huang CM, Tsai TF

The Journal of dermatology 2020; (47(9)):1046-1049 doi:10.1111/1346-8138.15470.

Etanercept for pediatric acrodermatitis continua of Hallopeau: A case report and literature review.

Ruggiero A, Patruno C, Napolitano M, et al.

Dermatologic therapy 2020; (33(6)):e14046 doi:10.1111/dth.14046.

[Acrodermatitis continua of Hallopeau and psoriatic arthritis: A case report].

García C, Arellano J, Vera V, Corredoira Y

Medwave 2020; (20(8)):e8021 doi:10.5867/medwave.2020.08.8021.

Interventions for chronic palmoplantar pustulosis: abridged Cochrane systematic review and GRADE assessments.

Obeid G, Do G, Kirby L, et al.

The British journal of dermatology 2021; (184(6)):1023-1032 doi:10.1111/bjd.19560.

Clinical characteristics, quality of life and risk factors for severity in palmoplantar pustulosis: a cross-sectional, multicentre study of 263 patients.

Sarıkaya Solak S, Kara Polat A, Kilic S, et al.

Clinical and experimental dermatology 2022; (47(1)):63-71 doi:10.1111/ced.14829.

Coping strategies in patients with acute myeloid leukemia.

Amonoo HL, Bodd MH, Reynolds MJ, et al.

Blood advances 2022; (6(7)):2435-2442 doi:10.1182/bloodadvances.2021005845.

Pustular psoriasis as an autoinflammatory keratinization disease (AiKD): Genetic predisposing factors and promising therapeutic targets.

Akiyama M

Journal of dermatological science 2022; (105(1)):11-17 doi:10.1016/j.jdermsci.2021.11.009.

Clinical Course and Characteristics of Generalized Pustular Psoriasis.

Choon SE, Navarini AA, Pinter A

American journal of clinical dermatology 2022; (23(Suppl 1)):21-29 doi:10.1007/s40257-021-00654-z.

Generalized pustular psoriasis rapidly and successfully treated with ixekizumab in a Caucasian patient.

Megna M, Abategiovanni L, Annunziata A, et al.

Dermatologic therapy 2022; (35(5)):e15382 doi:10.1111/dth.15382.

Acrodermatitis continua of Hallopeau successfully treated with ixekizumab: A case report.

Battista T, Guerrasio G, De Fata Salvatores G, et al.

Dermatologic therapy 2022; (35(5)):e15383 doi:10.1111/dth.15383.

A case of acrodermatitis continua of Hallopeau evolving into generalized pustular psoriasis successfully treated with guselkumab.

Yamamoto H, Kamiya K, Okada H, et al.

International journal of dermatology 2023; (62(2)):269-270 doi:10.1111/ijd.16153.

Palmoplantar pustulosis and acrodermatitis continua of Hallopeau: demographic and clinical comparative study in a large multicentre cohort.

Assan F, Husson B, Hegazy S, et al.

Journal of the European Academy of Dermatology and Venereology : JEADV 2022; (36(9)):1578-1583 doi:10.1111/jdv.18127.

Certolizumab Pegol: A New Therapeutic Approach for Acrodermatitis Continua of Hallopeau.

Rizzetto G, Diotallevi F, Molinelli E, et al.

Skin appendage disorders 2022; (8(2)):146-149 doi:10.1159/000519144.

Coping strategies and their association with diabetes specific distress, depression and diabetes self-care among people living with diabetes in Zambia.

Hapunda G

BMC endocrine disorders 2022; (22(1)):215 doi:10.1186/s12902-022-01131-2.

Pustular psoriasis in Malaysia: A review of the Malaysian Psoriasis Registry 2007-2018.

Teoh XY, Suganthy R, Voo SYM, et al.

Experimental dermatology 2023; (32(8)):1253-1262 doi:10.1111/exd.14770.

Deficiency of interleukin-36 receptor antagonist (DITRA): An analysis of 58 Chinese patients in a tertiary hospital in Taiwan.

Hsieh CY, Huang YW, Huang YH, Tsai TF

Experimental dermatology 2023; (32(8)):1272-1278 doi:10.1111/exd.14783.

Acrodermatitis Continua of Hallopeau Successfully Treated with Ustekinumab: A Case Report and Literature Review.

Shi L, Zeng L, Huang X, et al.

Clinical, cosmetic and investigational dermatology 2023; (16()):951-957 doi:10.2147/CCID.S404860.

Acrodermatitis continua of Hallopeau and generalised pustular psoriasis: Should they be the same or different entities?

Chularojanamontri L, Rattanakorn K, Julanon N, et al.

Experimental dermatology 2023; (32(8)):1235-1245 doi:10.1111/exd.14805.

The role of the interleukin-36 axis in generalized pustular psoriasis: a review of the mechanism of action of spesolimab.

Hawkes JE, Visvanathan S, Krueger JG

Frontiers in immunology 2023; (14()):1292941 doi:10.3389/fimmu.2023.1292941.

Generalized Pustular Psoriasis, Acute Generalized Exanthematous Pustulosis, and Other Pustular Reactions: A Clinical Review.

Gössinger E, Dodiuk-Gad R, Mühleisen B, et al.

Dermatologic clinics 2024; (42(2)):317-328 doi:10.1016/j.det.2024.01.001.

Successful treatment of acrodermatitis continua of Hallopeau coexisting with generalized pustular psoriasis with spesolimab: a case report.

Wen P, Liu C, Wang T, et al.

Frontiers in immunology 2024; (15()):1338285 doi:10.3389/fimmu.2024.1338285.

A retrospective analysis of 65 patients with acrodermatitis continua of Hallopeau.

Chularojanamontri L, Silpa-Archa N, Pattamadilok B, et al.

Experimental dermatology 2024; (33(3)):e15055 doi:10.1111/exd.15055.

Genetic analysis of different subtypes of aseptic pustulosis in the Chinese population.

Chen J, Xue X, Wang Z, et al.

Clinical and experimental dermatology 2024; (49(10)):1217-1226 doi:10.1093/ced/llae144.

Acrodermatitis continua of hallopeau: aggravating factors and treatment outcomes of 96 patients.

Yuan L, Yu X, Shi Y, et al.

The Journal of dermatological treatment 2024; (35(1)):2434098 doi:10.1080/09546634.2024.2434098.

Updated genetic background of generalized pustular psoriasis as an autoinflammatory keratinization disease.

Akiyama M

The Journal of dermatology 2025; (52(3)):400-407 doi:10.1111/1346-8138.17585.

Successful treatment of severe acrodermatitis continua of hallopeau with Bimekizumab: A case report.

Xu L, Li K, Mutter E, Langley A

SAGE open medical case reports 2025; (13()):2050313X241311043 doi:10.1177/2050313X241311043.

Evaluation of the psychosocial impact and received care in patients with gestational trophoblastic disease - a qualitative interview based study.

L J B, Y K E, S B, et al.

Journal of psychosomatic obstetrics and gynaecology 2025; (46(1)):2451992 doi:10.1080/0167482X.2025.2451992.

Case report: Successful treatment with spesolimab of acrodermatitis continua of Hallopeau in an older patient without IL36RN mutations.

Zheng J, Ding Y, Shi Y, Yi X

Frontiers in immunology 2024; (15()):1440102 doi:10.3389/fimmu.2024.1440102.

Enhancing mental health in adults with congenital heart disease: comparison of depression and anxiety screening tools.

Ehmann AL, Schütte E, Semmler J, et al.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2025; (67(5)) doi:10.1093/ejcts/ezaf145.

Apremilast Coadministered with Secukinumab for Effective Treatment of Acrodermatitis Continua of Hallopeau: A Case Report.

Yao XY, Liu LY, Yuan JX, et al.

Clinical, cosmetic and investigational dermatology 2025; (18()):1101-1105 doi:10.2147/CCID.S519344.

Spesolimab in generalized pustular psoriasis complicated by acrodermatitis continua of Hallopeau: a case report and mechanistic insights.

Hou XY, Xiao HL, Wang JY, et al.

Frontiers in immunology 2025; (16()):1563553 doi:10.3389/fimmu.2025.1563553.

Outcomes in Bimekizumab Treated Psoriasis Patients With Prior IL-17 Inhibitor Failure.

Song EJ, Pretorius P, Dasilva DR, et al.

Journal of psoriasis and psoriatic arthritis 2026; 24755303251412379 doi:10.1177/24755303251412379.